Aptatargets S.L.

Cardiovascular Emergency Care

Aptatargets S.L. is involved in clinical research for ST-elevation myocardial infarction in patients requiring urgent angioplasty, with attention to acute treatment settings and reperfusion care.

  • Myocardial infarction
  • Emergency angioplasty
  • Reperfusion therapy

The sponsor’s work in this area reflects a focus on acute cardiology and immediate intervention pathways for patients with severe coronary artery occlusion.

Acute Ischemic Stroke

The company also funds research in acute ischemic stroke, including early treatment approaches delivered before hospital arrival and linked to rapid neurological assessment.

  • Pre-hospital stroke care
  • Neurological emergency treatment
  • Arterial occlusion assessment

Its activity in this field is centered on urgent stroke management and care pathways designed for patients with suspected large-vessel ischaemia.

Thromboinflammatory Intervention

Across both disease areas, the sponsor’s research interest includes therapies aimed at modulating the thromboinflammatory response in acute vascular events.

  • Vascular inflammation
  • Thrombotic occlusion
  • Acute endothelial injury

This therapeutic domain links cardiovascular and neurovascular emergencies through shared mechanisms of ischemic injury.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of ApTOLL for Patients with ST Elevation Myocardial Infarction (STEMI)

    Not yet recruiting

    Investigated drugs:
    Spain
  • Study of ApTOLL for Treating Acute Ischemic Stroke in Patients Before Hospital Arrival

    Not yet recruiting

    Investigated diseases:
    Investigated drugs:
    Spain